Expert Opinion on Investigational Drugs, Volume 14, Issue 12 (2005)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 14, Issue 12 (2005)

See all volumes and issues
Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Volume 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Editorial

Article
17-AAG: mechanisms of antitumour activity
Panagiotis A Konstantinopoulos & Athanasios G Papavassiliou
Pages: 1471-1474
Published online: 25 Nov 2005
Abstractfor17-AAG: mechanisms of antitumour activity | References | PDF (97.6 KB)
  • 58 Views
  • 12 CrossRef citations
  • 0Altmetric

Review

Article
Targeting integrins for the control of tumour angiogenesis
Abebe Akalu, Alexandra Cretu & Peter C Brooks
Pages: 1475-1486
Published online: 25 Nov 2005
AbstractforTargeting integrins for the control of tumour angiogenesis | References | PDF (210.2 KB)
  • 80 Views
  • 24 CrossRef citations
  • 0Altmetric
Article
The glutamatergic system outside the CNS and in cancer biology
Niki Kalariti, Nikos Pissimissis & Michael Koutsilieris
Pages: 1487-1496
Published online: 25 Nov 2005
AbstractforThe glutamatergic system outside the CNS and in cancer biology | References | PDF (155.8 KB)
  • 276 Views
  • 41 CrossRef citations
  • 0Altmetric
Article
Histone deacetylase inhibitors: discovery and development as anticancer agents
Paul A Marks & Milos Dokmanovic
Pages: 1497-1511
Published online: 25 Nov 2005
AbstractforHistone deacetylase inhibitors: discovery and development as anticancer agents | References | PDF (221.6 KB)
  • 538 Views
  • 238 CrossRef citations
  • 0Altmetric
Article
Triclabendazole for the treatment of fascioliasis and paragonimiasis
Jennifer Keiser, Dirk Engels, Gottfried Büscher & Jürg Utzinger
Pages: 1513-1526
Published online: 25 Nov 2005
AbstractforTriclabendazole for the treatment of fascioliasis and paragonimiasis | References | PDF (187.1 KB)
  • 435 Views
  • 141 CrossRef citations
  • 0Altmetric
Article
New and improved glucocorticoid receptor ligands
Jeffrey N Miner, Mei Hua Hong & Andrés Negro-Vilar
Pages: 1527-1545
Published online: 25 Nov 2005
AbstractforNew and improved glucocorticoid receptor ligands | References | PDF (675.8 KB)
  • 120 Views
  • 60 CrossRef citations
  • 0Altmetric

Drug Evaluation

Article
The protein kinase C-β inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications
Aaron Vinik
Pages: 1547-1559
Published online: 25 Nov 2005
AbstractforThe protein kinase C-β inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications | References | PDF (204.4 KB)
  • 52 Views
  • 14 CrossRef citations
  • 0Altmetric

Key Paper Evaluation

Article
Potential of growth hormone-releasing hormone antagonists (JV-1-36 and JV-1-42) for the treatment of brain tumours
JAEGER LB, BANKS WA, VARGA JL, SCHALLY AV: Antagonists of growth hormone-releasing hormone cross the blood–brain barrier: a potential applicability to treatment of brain tumours. Proc. Natl. Acad. Sci. USA (2005) 102:12495-12500.
Sheila A Doggrell
Pages: 1561-1564
Published online: 25 Nov 2005
AbstractforPotential of growth hormone-releasing hormone antagonists (JV-1-36 and JV-1-42) for the treatment of brain tumours | References | PDF (94 KB)
  • 28 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles